Corporate News – Resonance Health Ltd. (RHT.AX)
Trading Performance
- Last 24‑hour performance: up 7.35 % as of 05:07 PM Central Europe on Wednesday 21 Oct 2026.
- Current price: AUD 0.08 per share on major exchanges.
- Shares outstanding: 444.4 million.
- Market capitalization: AUD 32.4 million.
- Trading volume (last 24 h): AUD 1.6 k.
- Year‑to‑date change: up 19.67 % since the end of the previous month.
- Simple moving average (200 days): AUD 0.05.
- 52‑week range: high AUD 0.09 (14 Oct 2026); low AUD 0.04 (27 Mar 2026).
Recent Corporate Development
Resonance Health Ltd. announced that it will present preliminary results from its extended‑proof‑of‑concept clinical trial for a non‑invasive MRI device that detects liver fibrosis.
- Presentation date: 28 Oct 2026.
- Format: Investor webinar hosted by CEO Andrew Harrison and Chief Scientific Officer Dr Wenjie Pang.
- Content: Trial design, methodology, and key outcomes.
- Background: The earlier proof‑of‑concept study demonstrated strong predictive capability for identifying liver fibrosis, a leading cause of mortality worldwide.
- Regulatory status: The company has previously obtained clearance for several AI‑based MRI devices and maintains a pipeline of imaging products aimed at non‑invasive assessment of liver and other diseases.
- Post‑event: A recording of the webinar will be made available shortly after the live event.
Related Stock Movements (Last 24 h)
| Ticker | Change | Current Price | Market Cap (AUD mn) | P/E Ratio |
|---|---|---|---|---|
| BLG.AX (Bluglass) | +2.5 % | 0.21 | 38 | – |
| D3E.AX (D3 Energy) | 0.0 % | 0.24 | 38.7 | – |
| WWG.AX (Wiseway) | +11.11 % | 0.25 | 38.7 | 9.19 |
| SEN.AX (Senetas) | +4.35 % | 2.27 | 38.1 | 97.27 |
| TRJ.AX (Trajan) | +8 % | 0.27 | 38.2 | – |
Company Overview
Resonance Health Ltd. focuses on developing and commercializing non‑invasive magnetic resonance imaging technology for measuring liver iron levels. The technology eliminates the need for invasive procedures, offering a safer diagnostic alternative. The company’s mission is to improve diagnostic accuracy and efficiency in healthcare. Resonance Health is listed on the ASX All Markets stock exchange and provides further information on its website: www.resonancehealth.com .
